Skip to main content
Top
Published in: European Archives of Oto-Rhino-Laryngology 1/2015

01-01-2015 | Otology

Effect of caffeic acid phenethyl ester on myringosclerosis development in the tympanic membrane of rat

Authors: Vefa Kinis, Musa Ozbay, Ulas Alabalik, Aylin Gul, Beyhan Yilmaz, Fazi Emre Ozkurt, Engin Sengul, Ismail Topcu

Published in: European Archives of Oto-Rhino-Laryngology | Issue 1/2015

Login to get access

Abstract

Myringosclerosis is hyalinization and calcification of certain areas of the tympanic membrane, especially the fibrous lamina propria layer and appears as white sclerotic lesions. Ventilation tube insertion is one of the most performed operations in the pediatric otorhinolaryngology practice to treat chronic otitis media with effusion. Myringosclerosis is a very common sequela of ventilation tube insertion. In this experimental study, our aim was to show the histopathological effects of caffeic acid phenethyl ester on myringosclerosis development in rat tympanic membrane after myringotomy. The rats were randomly categorized into four experimental groups including the comparison group (n = 4), non-treated group (n = 7), the saline (control) group (n = 7), the caffeic acid phenethyl ester group (n = 7). Non-treated group did not receive any treatment for 15 days. Saline (2.5 mL/kg, intraperitoneal) was administered to the third group once a day for 15 days. Fourth group received caffeic acid phenethyl ester intraperitoneally once a day at a dose of 10 μmol/kg for 15 days. Myringotomy was performed on the right tympanic membrane of all rats except comparison group using a sterile pick with the help of an operating microscope. Histopathological examination of myringosclerosis formation was done by a pathologist under light microscope. In histopathological analysis of groups, the severity of inflammation was milder in caffeic acid phenethyl ester group compared to non-treated and saline groups (p < 0.05). There was less myringosclerotic plaques in caffeic acid phenethyl ester group than in non-treated and saline groups (p < 0.05). TM thickness measurements were very close to each other in non-treated and saline groups. The tympanic membrane thickness of caffeic acid phenethyl ester group was much thinner than the other two groups (p < 0.05). Caffeic acid phenethyl ester decreases inflammation severity and the formation of myringosclerotic plaques. These two effects resulted in thinner tympanic membranes of rats which were treated with caffeic acid phenethyl ester. As a result, caffeic acid phenethyl ester has potential preventive effects on myringosclerosis development after myringotomy and ventilation tube insertion.
Literature
1.
go back to reference Albiin N, Hellström S, Salen B, Stenfors LE, Söderberg O (1983) The anatomy of the eustachian tube in the rat: a macro-and microscopical study. Anat Rec 207:513–521PubMedCrossRef Albiin N, Hellström S, Salen B, Stenfors LE, Söderberg O (1983) The anatomy of the eustachian tube in the rat: a macro-and microscopical study. Anat Rec 207:513–521PubMedCrossRef
2.
go back to reference Mattsson C, Marklund SL, Hellström S (1997) Application of oxygen free radical scavengers to diminish the occurrence of myringosclerosis. Ann Otol Rhinol Laryngol 106:513–518PubMedCrossRef Mattsson C, Marklund SL, Hellström S (1997) Application of oxygen free radical scavengers to diminish the occurrence of myringosclerosis. Ann Otol Rhinol Laryngol 106:513–518PubMedCrossRef
3.
go back to reference Mattsson C, Stierna P, Hellstrom S (2000) Treatment with dexamethasone arrests the development of myringosclerosis after myringotomy. Am J Otol 21:804–808PubMed Mattsson C, Stierna P, Hellstrom S (2000) Treatment with dexamethasone arrests the development of myringosclerosis after myringotomy. Am J Otol 21:804–808PubMed
4.
go back to reference Özcan C, Görür K, Cinel L, Talas DU, Unal M, Cinel I (2002) The inhibitory effect of topical N-acetylcysteine application on myringosclerosis in perforated rat tympanic membrane. Int J Pediatr Otorhinolaryngol 63:179–184PubMedCrossRef Özcan C, Görür K, Cinel L, Talas DU, Unal M, Cinel I (2002) The inhibitory effect of topical N-acetylcysteine application on myringosclerosis in perforated rat tympanic membrane. Int J Pediatr Otorhinolaryngol 63:179–184PubMedCrossRef
5.
go back to reference Tos M, Bonding P, Paulsen G (1983) Tympanosclerosis of the drum in secretory otitis media after insertion of grommets: a prospective, comparative study. J Laryngol Otol 97:489–496PubMedCrossRef Tos M, Bonding P, Paulsen G (1983) Tympanosclerosis of the drum in secretory otitis media after insertion of grommets: a prospective, comparative study. J Laryngol Otol 97:489–496PubMedCrossRef
6.
go back to reference Mattsson C, Magnuson K, Hellström S (1995) An increased oxygen concentration causes myringosclerosis in traumatized tympanic membranes. Experimental study. Ann Otol Rhinol Laryngol 104:625–632PubMedCrossRef Mattsson C, Magnuson K, Hellström S (1995) An increased oxygen concentration causes myringosclerosis in traumatized tympanic membranes. Experimental study. Ann Otol Rhinol Laryngol 104:625–632PubMedCrossRef
7.
go back to reference Uneri C, Sari M, Akboğa J, Yüksel M (2006) Vitamin E-coated tympanostomy tube insertion decreases the quantity of free radicals in tympanic membrane. Laryngoscope 116:140–143PubMedCrossRef Uneri C, Sari M, Akboğa J, Yüksel M (2006) Vitamin E-coated tympanostomy tube insertion decreases the quantity of free radicals in tympanic membrane. Laryngoscope 116:140–143PubMedCrossRef
8.
go back to reference Mattsson C, Hellström S (1997) Inhibition of the development of myringosclerosis by local administration of fenspiride, an anti-inflammatory drug. Eur Arch Otorhinolaryngol 254:425–429PubMedCrossRef Mattsson C, Hellström S (1997) Inhibition of the development of myringosclerosis by local administration of fenspiride, an anti-inflammatory drug. Eur Arch Otorhinolaryngol 254:425–429PubMedCrossRef
9.
go back to reference Asiri S, Hasham A, al Anazy F, Zakzouk S, Banyar A (1999) Tympanosclerosis: review of literature and incidence among patients with middle-ear infection. J Laryngol Otol 113:1076–1080PubMedCrossRef Asiri S, Hasham A, al Anazy F, Zakzouk S, Banyar A (1999) Tympanosclerosis: review of literature and incidence among patients with middle-ear infection. J Laryngol Otol 113:1076–1080PubMedCrossRef
10.
go back to reference Paparella MM, Schachern P (1994) New developments in treating otitis media. Ann Otol Rhinol Laryngol Suppl 163:7–10PubMed Paparella MM, Schachern P (1994) New developments in treating otitis media. Ann Otol Rhinol Laryngol Suppl 163:7–10PubMed
11.
go back to reference Liao HF, Chen YY, Liu JJ, Hsu ML, Shieh HJ, Liao HJ, Shieh CJ, Shiao MS, Chen YJ (2003) Inhibitory effect of caffeic acid phenethyl ester on angiogenesis, tumor invasion, and metastasis. J Agric Food Chem 51:7907–7912PubMedCrossRef Liao HF, Chen YY, Liu JJ, Hsu ML, Shieh HJ, Liao HJ, Shieh CJ, Shiao MS, Chen YJ (2003) Inhibitory effect of caffeic acid phenethyl ester on angiogenesis, tumor invasion, and metastasis. J Agric Food Chem 51:7907–7912PubMedCrossRef
12.
go back to reference Gokalp O, Uz E, Cicek E, Yilmaz HR, Ozer MK, Altunbas A, Ozcelik N (2006) Ameliorating role of caffeic acid phenethyl ester (CAPE) against isoniazid-induced oxidative damage in red blood cells. Mol Cell Biochem 290:55–59PubMedCrossRef Gokalp O, Uz E, Cicek E, Yilmaz HR, Ozer MK, Altunbas A, Ozcelik N (2006) Ameliorating role of caffeic acid phenethyl ester (CAPE) against isoniazid-induced oxidative damage in red blood cells. Mol Cell Biochem 290:55–59PubMedCrossRef
13.
go back to reference Sud’ina GF, Mirzoeva OK, Pushkareva MA, Korshunova GA, Sumbatyan NV, Varfolomeev SD (1993) Caffeic acid phenethyl ester as a lipoxygenase inhibitor with antioxidant properties. FEBS Lett 329:21–24PubMedCrossRef Sud’ina GF, Mirzoeva OK, Pushkareva MA, Korshunova GA, Sumbatyan NV, Varfolomeev SD (1993) Caffeic acid phenethyl ester as a lipoxygenase inhibitor with antioxidant properties. FEBS Lett 329:21–24PubMedCrossRef
14.
go back to reference Institute of Laboratory Animal Research. Commission on Life Sciences. National Research Council (1996) The guide for the care and use of laboratory animals, 7th edn. National Academy of Sciences, Washington, DC Institute of Laboratory Animal Research. Commission on Life Sciences. National Research Council (1996) The guide for the care and use of laboratory animals, 7th edn. National Academy of Sciences, Washington, DC
15.
go back to reference Banerjee T, Kuypers FA (2004) Reactive oxygen species and phosphatidylserine externalization in murine sickle red cells. Br J Haematol 124:392–402CrossRef Banerjee T, Kuypers FA (2004) Reactive oxygen species and phosphatidylserine externalization in murine sickle red cells. Br J Haematol 124:392–402CrossRef
16.
go back to reference Bhaya MH, Schachern PA, Morizono T, Paparella MM (1993) Pathogenesis of tympanosclerosis. Otolaryngol Head Neck Surg 109:413–420PubMed Bhaya MH, Schachern PA, Morizono T, Paparella MM (1993) Pathogenesis of tympanosclerosis. Otolaryngol Head Neck Surg 109:413–420PubMed
17.
go back to reference Spratley JE, Hellström SO, Mattsson CK, Pais-Clemente M (2001) Topical ascorbic acid reduces myringosclerosis in perforated tympanic membranes. A study in rat. Ann Otol Rhinol Laryngol 110:585–591PubMedCrossRef Spratley JE, Hellström SO, Mattsson CK, Pais-Clemente M (2001) Topical ascorbic acid reduces myringosclerosis in perforated tympanic membranes. A study in rat. Ann Otol Rhinol Laryngol 110:585–591PubMedCrossRef
18.
go back to reference Song JJ, Kwon SK, Cho CG, Park SW (2007) The effect of caffeic acid phenethyl ester on the prevention of experimentally induced myringosclerosis. Int J Pediatr Otorhinolaryngol 71:1287–1291PubMedCrossRef Song JJ, Kwon SK, Cho CG, Park SW (2007) The effect of caffeic acid phenethyl ester on the prevention of experimentally induced myringosclerosis. Int J Pediatr Otorhinolaryngol 71:1287–1291PubMedCrossRef
19.
go back to reference Dawes PJ, Bingham BJ, Ryhs R, Griffiths MV (1991) Aspirating middle ear effusions when inserting ventilation tubes: does it influence post-operative otorrhoea, tube obstruction or the development of tympanosclerosis? Clin Otolaryngol Allied Sci 16:457–461PubMedCrossRef Dawes PJ, Bingham BJ, Ryhs R, Griffiths MV (1991) Aspirating middle ear effusions when inserting ventilation tubes: does it influence post-operative otorrhoea, tube obstruction or the development of tympanosclerosis? Clin Otolaryngol Allied Sci 16:457–461PubMedCrossRef
21.
go back to reference Sade J, Luntz M (1993) Dynamic measurements of gas composition in the middle ear II: steady state value. Acta Otolaryngol 113:353–357PubMedCrossRef Sade J, Luntz M (1993) Dynamic measurements of gas composition in the middle ear II: steady state value. Acta Otolaryngol 113:353–357PubMedCrossRef
22.
go back to reference Felding JU, Rasmussen JB, Lildholdt T (1987) Gas composition of the normal and the ventilated middle ear cavity. Scand J Clin Lab Invest Suppl 186:31–41PubMedCrossRef Felding JU, Rasmussen JB, Lildholdt T (1987) Gas composition of the normal and the ventilated middle ear cavity. Scand J Clin Lab Invest Suppl 186:31–41PubMedCrossRef
23.
go back to reference Mattsson C, Carlsson L, Marklund SL, Hellström S (1997) Myringotomized mice develop myringosclerosis in the pars flaccida and not in the pars tensa. Laryngoscope 107:200–205PubMedCrossRef Mattsson C, Carlsson L, Marklund SL, Hellström S (1997) Myringotomized mice develop myringosclerosis in the pars flaccida and not in the pars tensa. Laryngoscope 107:200–205PubMedCrossRef
24.
go back to reference Fadillioglu E, Oztas E, Erdogan H, Yagmurca M, Sogut S, Ucar M, Irmak MK (2004) Protective effects of caffeic acid phenethyl ester on doxorubicin-induced cardiotoxicity in rats. J Appl Toxicol 24:47–52PubMedCrossRef Fadillioglu E, Oztas E, Erdogan H, Yagmurca M, Sogut S, Ucar M, Irmak MK (2004) Protective effects of caffeic acid phenethyl ester on doxorubicin-induced cardiotoxicity in rats. J Appl Toxicol 24:47–52PubMedCrossRef
25.
go back to reference Bakır S, Özbay M, Gün R, Yorgancılar E, Kınış V, Keleş A, Abakay A, Gökalp O, Topçu İ (2013) The protective role of caffeic acid phenethyl ester against streptomycin ototoxicity. Am J Otolaryngol 34:16–21PubMedCrossRef Bakır S, Özbay M, Gün R, Yorgancılar E, Kınış V, Keleş A, Abakay A, Gökalp O, Topçu İ (2013) The protective role of caffeic acid phenethyl ester against streptomycin ototoxicity. Am J Otolaryngol 34:16–21PubMedCrossRef
26.
go back to reference Irmak MK, Fadillioglu E, Sogut S, Erdogan H, Gulec M, Ozer M, Yagmurca M, Gozukara ME (2003) Effects of caffeic acid phenethyl ester and alpha-tocopherol on reperfusion injury in rat brain. Cell Biochem Funct 21:283–289PubMedCrossRef Irmak MK, Fadillioglu E, Sogut S, Erdogan H, Gulec M, Ozer M, Yagmurca M, Gozukara ME (2003) Effects of caffeic acid phenethyl ester and alpha-tocopherol on reperfusion injury in rat brain. Cell Biochem Funct 21:283–289PubMedCrossRef
27.
go back to reference Kazikdas KC, Uguz MZ, Erbil G, Tugyan K, Yilmaz O, Guneli E, Altun Z (2006) The antioxidant effect of alpha-tocopherol in the prevention of experimentally induced myringosclerosis. Otol Neurotol 27:882–886PubMedCrossRef Kazikdas KC, Uguz MZ, Erbil G, Tugyan K, Yilmaz O, Guneli E, Altun Z (2006) The antioxidant effect of alpha-tocopherol in the prevention of experimentally induced myringosclerosis. Otol Neurotol 27:882–886PubMedCrossRef
28.
go back to reference Akbaş Y, Pata YS, Görür K, Polat G, Polat A, Ozcan C, Unal M (2003) Hear Res. The effect of l-carnitine on the prevention of experimentally induced myringosclerosis in rats. Hear Res 184:107–112PubMedCrossRef Akbaş Y, Pata YS, Görür K, Polat G, Polat A, Ozcan C, Unal M (2003) Hear Res. The effect of l-carnitine on the prevention of experimentally induced myringosclerosis in rats. Hear Res 184:107–112PubMedCrossRef
29.
go back to reference Dogan E, Erdag TK, Sarioglu S, Ecevit MC, Ikiz AO, Güneri EA (2011) The preventive effect of N-nitro l-arginine methyl ester in experimentally induced myringosclerosis. Int J Pediatr Otorhinolaryngol 75:1035–1039PubMedCrossRef Dogan E, Erdag TK, Sarioglu S, Ecevit MC, Ikiz AO, Güneri EA (2011) The preventive effect of N-nitro l-arginine methyl ester in experimentally induced myringosclerosis. Int J Pediatr Otorhinolaryngol 75:1035–1039PubMedCrossRef
30.
go back to reference Emir H, Kaptan ZK, Samim E, Sungu N, Ceylan K, Ustun H (2009) The preventive effect of ginkgo biloba extract in myringosclerosis: study in rats. Otolaryngol Head Neck Surg 140:171–176PubMedCrossRef Emir H, Kaptan ZK, Samim E, Sungu N, Ceylan K, Ustun H (2009) The preventive effect of ginkgo biloba extract in myringosclerosis: study in rats. Otolaryngol Head Neck Surg 140:171–176PubMedCrossRef
Metadata
Title
Effect of caffeic acid phenethyl ester on myringosclerosis development in the tympanic membrane of rat
Authors
Vefa Kinis
Musa Ozbay
Ulas Alabalik
Aylin Gul
Beyhan Yilmaz
Fazi Emre Ozkurt
Engin Sengul
Ismail Topcu
Publication date
01-01-2015
Publisher
Springer Berlin Heidelberg
Published in
European Archives of Oto-Rhino-Laryngology / Issue 1/2015
Print ISSN: 0937-4477
Electronic ISSN: 1434-4726
DOI
https://doi.org/10.1007/s00405-013-2832-2

Other articles of this Issue 1/2015

European Archives of Oto-Rhino-Laryngology 1/2015 Go to the issue